OHSU Rare Disease Research Consortium Symposium 2015: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(New page: {{Template:OHSU Rare Disease Research Consortium Symposium 2015}}) |
No edit summary |
||
Line 1: | Line 1: | ||
{{Template:OHSU Rare Disease Research Consortium Symposium 2015}} | {{Template:OHSU Rare Disease Research Consortium Symposium 2015}} | ||
==General Info== | |||
== Schedule == | |||
<div style="padding: 10px; width: 720px; border: 5px solid #B3CD4E;"> | |||
{| border="1" cellpadding="3" cellspacing="0" style="border:#c9c9c9 1px solid; margin: 1em 1em 1em 0; border-collapse: collapse; width:710px" <!-- This line here formats your table for you. Change the code to change the formatting of your table.--> | |||
| align="center" style="background:#f0f0f0;"|'''Time''' | |||
| align="center" style="background:#f0f0f0;"|'''Presenter''' | |||
| align="center" style="background:#f0f0f0;"|'''Title''' | |||
|-- | |||
| 3:30 pm | |||
| Registration | |||
| | |||
|-- | |||
| 4:00-5:00 | |||
| Sekar Kathiresan, M.D. | |||
| Leveraging human knockouts to understand risk for and protection from disease | |||
|-- | |||
| 5:00 to 6:10 | |||
| | |||
| Poster session and reception | |||
|-- | |||
| 6:10 to 6:20 | |||
| Mary Stenzel-Poore, Ph.D., Senior Associate Dean for Research, School of Medicine | |||
| Introduction | |||
|-- | |||
| 6:20 to 6:30 | |||
| Laura Hays, Ph.D., Executive Director, Fanconi Anemia Research Fund | |||
| Making a difference: the David Frohnmayer advocacy formula | |||
|-- | |||
| 6:30 to 6:35 | |||
| Maureen Hoatlin | |||
| OHSU Rare Disease Consortium overview and objective of the symposium | |||
|-- | |||
| 6:35 to 6:45 | |||
| Eric Orwoll, M.D. | |||
| Osteogenesis imperfecta: a brittle bone disease with well-definedmolecular pathologies but limited clinical insights and therapies | |||
|-- | |||
| 6:45 to 6:55 | |||
| David Sprio, M.D. | |||
| A novel Real patient video platform that enables patients and clinicians to share rare disease phenotypes | |||
|-- | |||
| 6:55 to 7:05 | |||
| Evan Shereck, M.D. | |||
| Overview of the program in Pediatric Immunodeficiency Rare Disease Research Clinical Network | |||
|-- | |||
|7:05 to 7:10 | |||
| Markus Grompe, M.D. | |||
| Program in Fanconi anemia | |||
|-- | |||
| 7:10 to 7:20 | |||
| Cary O. Harding, M.D. | |||
| Clinical Trials in inborn errrors of amino acid and fatty acid metabolism | |||
|-- | |||
| 7:20 to 7:40 | |||
| David Ellison, M.D. | |||
| Part 1:All about that Bass: rare gene mutations and human blood pressure variation. Part 2: How OCTRI can help rare disease research at OHSU | |||
|-- | |||
| 7:40 to 8:20 | |||
| Xiaobing Quan, M.D., Ph.D | |||
| Accelerating opportunities from discovery to clinic in rare disease research | |||
|-- | |||
|8:20 to 8:25 | |||
|Maureen Hoatlin | |||
|Final Remarks, Action items, organizing for the future | |||
|-- | |||
|8;25 to 8:30 | |||
| | |||
|iPad Giveaway | |||
|} | |||
</div> |
Revision as of 18:04, 30 March 2015
April 7, 2015, from 4-8:30 pm at OHSU in the Joseph Vey Conference Center
General InfoSchedule
|